The result suggested that a therapeutic method of TG combined with LEF significantly decreased CRP in RA treatment when compared with control treatment (MD = −4.04, 95% CI (−4.93, −3.14), P < 0.0001) (Figure 5(b)). The gene discussed is CRP; the disease is rheumatoid arthritis.